Felix Enwa

Dr. Felix Enwa


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2025 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
HCHaiou Cao
Haiou Cao
FEFelix Enwa
Felix Enwa
ALAmaliya Latypova
Amaliya Latypova
MAMunthar Kadhim Abosaoda
Munthar Kadhim Abosaoda
GZGaffar Sarwar Zaman
Gaffar Sarwar Zaman
ADAnita Devi
Anita Devi
Modern healthcare depends fundamentally on clinical biochemistry for disease diagnosis and therapeutic guidance. The discipline encounters operational constraints, including sampling inefficiencies, precision limitations, and expansion difficulties. Recent advancements in established technologies, such as mass spectrometry and the development of high-throughput screening and point-of-care technologies, are revolutionizing the industry. Modern biosensor technology and wearable monitors facilitate continuous health tracking, Artificial Intelligence (AI)/machine learning (ML) applications enhance analytical capabilities, generating predictive insights for individualized treatment protocols. However, concerns regarding algorithmic bias, data privacy, lack of transparency in decision-making (“black box” models), and over-reliance on automated systems pose significant challenges that must be addressed for responsible AI integration. However, significant limitations remain—substantial implementation expenses, system incompatibility issues, and information security vulnerabilities intersect with ethical considerations regarding algorithmic fairness and protected health information. Addressing these challenges demands coordinated efforts between clinicians, scientists, and technical specialists. This review discusses current challenges in clinical biochemistry, explicitly addressing the limitations of reference intervals and barriers to implementing innovative biomarkers in medical settings. The discussion evaluates how advanced technologies and multidisciplinary collaboration can overcome these constraints while identifying research priorities to enhance diagnostic precision and accessibility for better healthcare delivery.

3 December 2024 in Human Immunology
Verified
Journal Article
Closed access
MAMohammad Y. Alshahrani
Mohammad Y. Alshahrani
FEFelix Enwa
Felix Enwa
JRJasur Rizaev
Jasur Rizaev
AKAshishkumar Kyada
Ashishkumar Kyada
RRR. Roopashree
R. Roopashree
MAMunthar Kadhim Abosaoda
Munthar Kadhim Abosaoda

1 January 2023 in Journal Of Biochemical Technology
Verified
Journal Article
Open access
FEFelix Enwa
Felix Enwa
OEOlivia Sochi Egbule
Olivia Sochi Egbule
LOLevison Obaro Oyubu
Levison Obaro Oyubu
CDCynthia Nguevese Damera
Cynthia Nguevese Damera
TMTovia Osose Momoh
Tovia Osose Momoh
Staphylococcus aureus poses a cause of concern in various healthcare settings, causing a number of infections ranging from mild to severe. The evolution of new genetically distinct multi-drug resistant strains, such as the Methicillin-Resistant Staphylococcus aureus, has only amplified the problem. Having efficient data on the local antimicrobial susceptibility pattern of this pathogen is necessary for the selection of appropriate antibiotics for combating infections that may arise from Staphylo


24 December 2024 in Biochemical Genetics
Verified
Journal Article
Closed access
PDF file
FEFelix Enwa
Felix Enwa
AKAbdulrahman Qais Khaleel
Abdulrahman Qais Khaleel
JRJasur Alimdjanovich Rizaev
Jasur Alimdjanovich Rizaev
RRR. Roopashree
R. Roopashree
MSMuath Suliman
Muath Suliman
MAMunther Kadhim Abosaoda
Munther Kadhim Abosaoda

31 January 2025 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
MZMohammad Zamanian
Mohammad Zamanian
ZKZahra Kamran
Zahra Kamran
MTMarziye Ranjbar Tavakoli
Marziye Ranjbar Tavakoli
FEFelix Enwa
Felix Enwa
MAMohammad Abohassan
Mohammad Abohassan
RAResan Shakir Abdulamer
Resan Shakir Abdulamer